The average numbers of detected CD45−/GFP+ cells were 11.1, 9.1, 8.7, 15.0, 15.5, 6.5, 18.2, and 43.1 for NSCLC-AD, NSCLC-SC, SCLC, CC, GC, glioma, HCC, and PC patients, respectively (Figure 5C). This evidence concerns the gene PTPRC and small cell lung carcinoma.